We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®

News   May 12, 2011

 
Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®
 
 
 

RELATED ARTICLES

Enhancing the Infection-fighting Potential of Natural Products

News

A team has identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA.

READ MORE

“VEGAS” Technique Could Lead to New Scientific Tools and Treatments

News

The technique, dubbed VEGAS, works in mammalian cells and can yield useful new molecules within days, providing scientist with a powerful new research tool and a potential route to better therapeutics for various diseases.

READ MORE

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE